Tristan Maguet joined Gilde in 2022 and focuses on the Therapeutics sector. He is involved in deal sourcing, due diligence and portfolio management.
Prior to joining Gilde, Tristan was an Investment Analyst at a Mutual Fund specialized in publicly listed European and US based Biotech companies. Before this, Tristan was also active as a Venture Capital Analyst at Andera Partners’ Biodiscovery Fund where he helped analyzing investment opportunities, deal engineering, sector landscaping studies and Fund reporting.
Tristan has a Pharm.D from Université Grenoble Alpes and an MSc in Management from ESSEC Business School in Paris, France.
He is a French citizen based in Gilde’s Utrecht office.